These findings should be interpreted cautiously given the limited data available for some subgroup analyses
Research gap analysis derived from 3 medicine papers in our local library.
The gap
However, these findings should be interpreted cautiously given the limited data available for some subgroup analyses, the absence of consistently significant interaction tests, and variability in the reporting of background heart failure therapies across the included trials.
Evidence profile
Sourced from the limitations section and conclusions and recommendations of the source papers, classified as general, spanning 3 journals.
Research trend
Established — well-defined area with open sub-problems.
Supporting evidence — 3 representative gaps
- The Prognostic Value of Left Atrial Size and Strain Assessed by Cardiac Magnetic Resonance in the Coronary Chronic Total Occlusion (2026) · Journal of Cardiovascular Development and Disease · doi
This was a single-center retrospective cohort study with a relatively small sample size. Patients with overt heart failure were limited in number; therefore, the present analysis primarily included patients with LVEF ≥ 40%, which may limit generalizability to populations with more advanced systolic dysfunction. Revascularization strategies and procedural success were not uniform across the study population, particularly in patients with MVD, reflecting real-world clinical practice; therefore, residual confounding related to interventional strategy cannot be excluded.
generallimitations sectionKeywords: was single-center retrospective cohort study relatively small sample - The Efficacy of Glucagon-like Peptide-1 Based Therapies in Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Systematic Review and Meta-Analysis (2026) · Journal of Clinical Medicine · doi
However, these findings should be interpreted cautiously given the limited data available for some subgroup analyses, the absence of consistently significant interaction tests, and variability in the reporting of background heart failure therapies across the included trials. As such, our results should be considered hypothesis-generating and may contribute to future re- search aimed at clarifying whether a more phenotype-specific approach to the use of these agents in HF management is warranted.
generalconclusionsevidence 5/5Keywords: interpreted cautiously given limited available subgroup analyses absence consistently significant interaction tests variability reporting background - Draft Document for Public Consultation: What is new and what has changed in the 2026 Global Heart Failure Implementation Guidelines and why (2026) · Global Cardiology · doi
No. 9-01 Future clinical trials in HF should preferentially classify patients as HFrEF (LVEF <50%) or HFpEF (LVEF ≥50%). 9-02 Patients with LVEF 41–49% should generally be included within HFrEF trial populations, unless there is a specific scientific rationale otherwise. 9-03 Future therapeutic trials may alternatively enroll patients across the entire LVEF spectrum or according to underlying disease phenotypes and evaluate treatment effects continuously rather than using arbitrary EF categories. R: Recommend; Su: Suggest; HFrEF: Heart Failure with reduced ejecGon fracGon; LVEF: leI ventricular ejecGon fracGon; HFpEF: heart failure with preserved ejecGon fracGon. R R
generalrecommendationsevidence 5/5Keywords: lvef patients hfref ejecgon fracgon future trials hfpef heart failure clinical preferentially classify generally included
Questions about this gap
Explore this gap further
Run this gap as a query across open scholarly engines for the latest related literature.
Working on this gap? Review it with us.
AI Review reads your manuscript in one pass with 8 specialist agents, calibrated on 69K+ real peer reviews.
Tools for your next paper
Related gaps in Medicine
- The lack of standardized evaluation metrics and benchmarkThe lack of standardized evaluation metrics and benchmark datasets makes it difficult to compare different approaches objectively. Most…
- The evidence base is limited by small sample sizesThe evidence base is limited by small sample sizes, inconsistent reporting of baseline tooth characteristics, and variability in RET…
- The variability in patient response to different splintThe variability in patient response to different splint designs, which can affect the clinical outcomes. Another challenge is the need for…
- Future high-quality clinical trials are neededFuture high-quality clinical trials are needed to validate and refine these strategies for more precise and effective patient treatments.